This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Tuberous Sclerosis, Angiofibroma, Hypomelanotic Macule or Plaque
and you are
over 3
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The purpose of this trial is to evaluate the efficacy and safety of NPC-12G gel (topical formulation of sirolimus) versus placebo gel to facial angiofibroma and other skin lesions in patients with tuberous sclerosis complex (TSC)

Provided treatments

  • Drug: NPC-12G gel
  • Drug: Placebo gel

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02635789. The sponsor of the trial is Nobelpharma and it is looking for 62 volunteers for the current phase.
Official trial title:
A Double-blind, Randomized, Placebo-controlled Phase III Trial to Investigate the Efficacy and Safety of NPC-12G Gel (Topical Formulation of Sirolimus) to Angiofibroma and Other Skin Lesions in Patients With Tuberous Sclerosis Complex